Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mario Masrur

Surgery Chicago, IL Medical Doctor

NPI 1811254568 CMS profile 1314042

1801 W Taylor St, 3F - Occ, Chicago, IL 60612

Open in the dashboard

General payments

$67,393

232 records reported · program years 2019–2025

Research payments

$1,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mario Masrur of Chicago, IL is reported in the CMS Open Payments database as having received $67,393 across 232 general payments and $1,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,578 20
2024 General $1,141 20
2023 General $20,742 37
2022 General $4,153 39
2022 Research $1,000 1
2021 General $27,664 56
2020 General $7,745 10
2019 General $4,370 50

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mario Masrur
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Mario Masrur were reported at $1,578. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Mario Masrur Surgery median Middle half National median
2019 $4,370 $253 $82–$1,521 $163
2020 $7,745 $131 $40–$706 $114
2021 $27,664 $168 $50–$904 $132
2022 $4,153 $224 $76–$1,218 $149
2023 $20,742 $253 $82–$1,255 $160
2024 $1,141 $279 $90–$1,381 $164
2025 $1,578 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $41,008 139 payments
  2. Intuitive Surgical, Inc. $12,594 10 payments
  3. Covidien LP $11,842 55 payments
  4. W. L. Gore & Associates, Inc. $793 8 payments
  5. Davol Inc. $517 10 payments
  6. Dilon Technologies, Inc. $172 1 payment
  7. Enterra Medical, Inc. $125 3 payments
  8. Histosonics, Inc. $108 1 payment
  9. Baxter Healthcare $103 1 payment
  10. Bard Peripheral Vascular, Inc. $82 1 payment
  11. Other $50 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $36,400 21 payments
  2. Education $12,008 4 payments
  3. Food and Beverage $10,334 180 payments
  4. Consulting Fee $5,559 4 payments
  5. Travel and Lodging $3,093 23 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $12,594 10 payments
  2. Signia $4,720 69 payments
  3. LigaSure Vessel Sealing $2,462 22 payments
  4. Sonicision Ultrasonic Dissection $2,067 7 payments
  5. LigaSure Vessel Sealing $1,048 6 payments
  6. SurgiSleeve $404 2 payments
  7. GORE ENFORM Preperitoneal Biomaterial $374 3 payments
  8. iDrive $323 3 payments
  9. Sonicision Ultrasonic Dissection $296 6 payments
  10. PHASIX $236 6 payments
  11. Other $1,813 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $1,000 1 payment

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$21,484

Medicare's payments for the services billed

Medicare patients

60

Average age 58

Services billed

112

38 women, 22 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 57%
Arthritis 47%
Chronic kidney disease 45%
Ischemic heart disease 33%
COPD 27%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

233 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record